DK2822568T3 - Anvendelser af caseinsammensætninger - Google Patents

Anvendelser af caseinsammensætninger Download PDF

Info

Publication number
DK2822568T3
DK2822568T3 DK13757439.8T DK13757439T DK2822568T3 DK 2822568 T3 DK2822568 T3 DK 2822568T3 DK 13757439 T DK13757439 T DK 13757439T DK 2822568 T3 DK2822568 T3 DK 2822568T3
Authority
DK
Denmark
Prior art keywords
case compositions
compositions
case
Prior art date
Application number
DK13757439.8T
Other languages
English (en)
Inventor
Aaron Calvin Fanning
Hasmukh Ambalal Patel
Johannes Schalk
Ramon Stafford Hall
Roger Richard Schwarzenbach
Sergey Yevgenievich Ukraintsev
Original Assignee
Fonterra Co-Operative Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49117099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2822568(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fonterra Co-Operative Group Ltd filed Critical Fonterra Co-Operative Group Ltd
Application granted granted Critical
Publication of DK2822568T3 publication Critical patent/DK2822568T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DK13757439.8T 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger DK2822568T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261608858P 2012-03-09 2012-03-09
PCT/NZ2013/000035 WO2013133727A1 (en) 2012-03-09 2013-03-11 Uses of casein compositions

Publications (1)

Publication Number Publication Date
DK2822568T3 true DK2822568T3 (da) 2020-08-10

Family

ID=49117099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13757439.8T DK2822568T3 (da) 2012-03-09 2013-03-11 Anvendelser af caseinsammensætninger

Country Status (14)

Country Link
US (3) US20150011468A1 (da)
EP (1) EP2822568B1 (da)
JP (1) JP6420156B2 (da)
CN (1) CN104159592B (da)
AU (1) AU2013202942B2 (da)
DK (1) DK2822568T3 (da)
ES (1) ES2811759T3 (da)
HK (1) HK1205947A1 (da)
HR (1) HRP20201197T1 (da)
HU (1) HUE050010T2 (da)
LT (1) LT2822568T (da)
NZ (1) NZ700686A (da)
PL (1) PL2822568T3 (da)
WO (1) WO2013133727A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016110842A (ru) * 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Композиции и составы для предотвращения и уменьшения опухолеобразования, пролиферации и инвазии раковых клеток, и способы их получения и применения при лечении раковых заболеваний
CA2971806C (en) * 2014-12-26 2022-05-03 Compagnie Gervais Danone Product comprising a container and whey protein
BR112017024975B1 (pt) * 2015-05-22 2022-03-15 The A2 Milk Company Limited Uso de leite bovino contendo beta-caseína
TWI761487B (zh) * 2017-04-06 2022-04-21 日商明治股份有限公司 用於促進血中胺基酸濃度上升之發酵乳
EP3703727A1 (en) 2017-10-30 2020-09-09 FrieslandCampina Nederland B.V. Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength
JP7292012B2 (ja) 2018-06-14 2023-06-16 株式会社クボタ コンバイン
EP4136979A1 (en) * 2020-04-13 2023-02-22 Godo Shusei Co., Ltd. Fermented milk, manufacturing method therefor, and dephosphorylated milk
US20210352938A1 (en) * 2020-05-12 2021-11-18 Raymond L. Sullivan, JR. Novel drink
JP7282061B2 (ja) 2020-06-25 2023-05-26 株式会社クボタ コンバイン
US20220030923A1 (en) * 2020-07-17 2022-02-03 Northern Innovations Holding Corp. Caffeine and Alpha Lipoic Acid Compositions for Enhanced Sensory Effects
US20220225640A1 (en) * 2021-01-19 2022-07-21 Alexia Ramos Multipurpose Beverage Composition
WO2022225770A1 (en) * 2021-04-19 2022-10-27 Abbott Laboratories High protein liquid nutritional compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501676A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Calcium-depleted milk protein products and use in cheese manufacture to reduce nugget-formation
NZ501675A (en) * 1999-12-09 2002-12-20 New Zealand Dairy Board Translucent milk drink having a pH of 5.7 to 7.0 and a percentage transmission of at least 5% prepared by a cation exchange process
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
NZ523394A (en) * 2002-12-24 2006-03-31 New Zealand Dairy Board Dairy protein processing and applications thereof
WO2010126353A1 (en) 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
RU2012125877A (ru) * 2010-01-29 2014-03-10 Эбботт Лэборетриз Питательные эмульсии, содержащие бета-гидрокси-бета-метилбутират кальция (гмб кальция) и растворимый белок
ES2902931T3 (es) * 2010-07-16 2022-03-30 Fonterra Cooperative Group Ltd Producto lácteo y proceso

Also Published As

Publication number Publication date
EP2822568B1 (en) 2020-06-17
AU2013202942A1 (en) 2013-09-26
ES2811759T3 (es) 2021-03-15
PL2822568T3 (pl) 2020-11-16
NZ700686A (en) 2016-08-26
US20190105371A1 (en) 2019-04-11
JP2015509531A (ja) 2015-03-30
AU2013202942B2 (en) 2016-05-12
EP2822568A4 (en) 2015-11-11
CN104159592B (zh) 2018-10-19
LT2822568T (lt) 2020-09-10
CN104159592A (zh) 2014-11-19
JP6420156B2 (ja) 2018-11-07
WO2013133727A1 (en) 2013-09-12
US20150011468A1 (en) 2015-01-08
HK1205947A1 (en) 2015-12-31
EP2822568A1 (en) 2015-01-14
HUE050010T2 (hu) 2020-11-30
HRP20201197T1 (hr) 2020-11-13
US20170232063A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
SMT201700094B (it) Composto di pirazina carbossammide
DK3725778T3 (da) Formuleringer af enzalutamid
DK2911506T3 (da) Driftreducerende sammensætninger
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK3336097T3 (da) Fremstilling af ikke-krystallinsk obeticholsyre
BR112015002651A2 (pt) composições cosméticas
BR112013017183A2 (pt) composições de bepostatina
DK2822568T3 (da) Anvendelser af caseinsammensætninger
BR112014032798A2 (pt) composição
CO6930368A2 (es) Composiciones de yodo-povidona estable
DK3461895T3 (da) Modulation af ube3a-ats-ekspression
BR112015003038A2 (pt) composições lubrificantes
BR112015001562A2 (pt) biotinas e composições
DK3450434T3 (da) Deutererede derivater af ruxolitinib
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
DK2822967T3 (da) Compositions comprising secretory - like immunoglobulins
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
DK2919777T3 (da) Transmukosal afgivelse af tocotrienol
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c
FR2993777B1 (fr) Composition photo-protectrice
DK2965026T3 (da) Generering af slushice
DK2852392T3 (da) Anvendelser af ikke-sulfateret chondroitin
BR112014032712A2 (pt) composição
CL2015001192A1 (es) Composición herbicida